Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Ranges

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Experimental Medicine|October 1, 1987
Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alphaG E Ranges, I S Figari, T Espevik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1988
Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1T Espevik, I S Figari, G E Ranges, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1991
Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1L D Johns, K C Flanders, G E Ranges, et al.
The Journal of Experimental Medicine|October 1, 1982
T cell development in normal and thymopentin-treated nude miceG E Ranges, G Goldstein, E A Boyse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1978
Genetic control of tolerance induction to human gamma-globulin in miceM M Azar, G E Ranges, E J Yunis, et al.
Immunopharmacology|August 1, 1985
Interleukin-2 and aging: decreased interleukin-2 production in healthy older people does not correlate with reduced helper cell numbers or antibody response to influenza vaccine and is not corrected in vitro by thymosin alpha 1W B Ershler, A L Moore, K Roessner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1983
Suppression of T cell cytotoxicity by nude mouse spleen cells: reversal by monosaccharides and interleukin 2M A Palladino, G E Ranges, M P Scheid, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Functional relationships of Lyt-2 and Lyt-3 expression and T-cell cytotoxicity: a new model systemM A Palladino, G E Ranges, H F Oettgen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1990
Serotonin-activated signal transduction via serotonin receptors on Jurkat cellsT M Aune, K A Kelley, G E Ranges, et al.
International Reviews of Immunology|September 1, 1988
In vivo modulation of murine collagen induced arthritisG E Ranges, S Fortin, M T Barger, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Experimental Medicine|October 1, 1987
Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alphaG E Ranges, I S Figari, T Espevik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1988
Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1T Espevik, I S Figari, G E Ranges, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1991
Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1L D Johns, K C Flanders, G E Ranges, et al.
The Journal of Experimental Medicine|October 1, 1982
T cell development in normal and thymopentin-treated nude miceG E Ranges, G Goldstein, E A Boyse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1978
Genetic control of tolerance induction to human gamma-globulin in miceM M Azar, G E Ranges, E J Yunis, et al.
Immunopharmacology|August 1, 1985
Interleukin-2 and aging: decreased interleukin-2 production in healthy older people does not correlate with reduced helper cell numbers or antibody response to influenza vaccine and is not corrected in vitro by thymosin alpha 1W B Ershler, A L Moore, K Roessner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1983
Suppression of T cell cytotoxicity by nude mouse spleen cells: reversal by monosaccharides and interleukin 2M A Palladino, G E Ranges, M P Scheid, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Functional relationships of Lyt-2 and Lyt-3 expression and T-cell cytotoxicity: a new model systemM A Palladino, G E Ranges, H F Oettgen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1990
Serotonin-activated signal transduction via serotonin receptors on Jurkat cellsT M Aune, K A Kelley, G E Ranges, et al.
International Reviews of Immunology|September 1, 1988
In vivo modulation of murine collagen induced arthritisG E Ranges, S Fortin, M T Barger, et al.
Pageof 4